How do you read the Tesamorelin sequence?
Tesamorelin's structure is described by both an amino-acid sequence and chemical modifications. A sequence line containing 44 positions therefore does not necessarily represent the entire structure on its own. Here we separate the chain's residues from the information at its two ends.
Follow the 44 positions in order
FDA substance record MQG94M5EEO shows a sequence of 44 amino-acid residues. It starts with Tyr–Ala–Asp and ends with Leu. In the record's one-letter code, these parts correspond to YAD and L respectively. The modifications are displayed separately from the letter sequence itself.
Under the IUPAC convention, peptide sequences are normally written from the N-terminus to the C-terminus, left to right. Numbering follows the same direction. Identify the beginning and end before comparing two sequence descriptions.
The hexenoyl group belongs at the beginning
ChEBI describes a hex-3-enoyl group attached to the N-terminal tyrosine residue. FDA's chemical description specifies that the group has six carbon atoms and a double bond at position 3. This position number refers to the carbon chain in the modification, not the third amino acid.
It is therefore a chemical group at the first residue, not an extra amino acid before Tyr. The addition does not give the chain 45 amino-acid residues. When describing the structure, include both the sequence and this N-terminal modification.
Leu-NH2 specifies the other terminal group
FDA's GSRS lists leucinamide at position 44. In IUPAC's amide notation, this terminal group is written Leu-NH2: the C-terminal group is an amide, –CONH2. NH2 is not an additional amino acid after Leu and should not be counted as position 45.
Leu and Leu-NH2 therefore provide different amounts of information about the terminal group. If a source only displays the one-letter sequence, also read its field or footnote for terminal modifications.
The molecular formula does not show the order
ChEBI gives the molecular formula C221H366N72O67S. The numbers count atoms of each element; for example, 221 denotes carbon atoms, not the number of amino-acid residues. The formula does not state the order of the residues.
These are therefore two different checks: does the stated atomic composition match, and does the chain's order match together with its modifications? Matching formulas do not replace a comparison of the structures.
Record the difference where it occurs
When comparing two documents, first record which source and version each piece of information comes from. Then check the residue count, order and both terminal groups separately. If something is missing, record that the information is missing instead of adding it based on the product name.
The product link and introductory guide are below. The sources explain the published molecular structure; they do not verify the identity or quality of the store's materials.
Related research standards
Related articles
Research use only. Invus Labs products are laboratory reference standards for in-vitro research — not for human or veterinary use.